INTERVENTION 1:	Intervention	0
Prone	Intervention	1
Prone position	Intervention	2
position	HP:0012830	6-14
INTERVENTION 2:	Intervention	3
Supine	Intervention	4
Supine position	Intervention	5
position	HP:0012830	7-15
Inclusion Criteria:	Eligibility	0
Patients should have had breast-conserving surgery for breast cancer or DCIS (Ductal Carcinoma in Situ)	Eligibility	1
surgery	OAE:0000067	43-50
breast cancer	DOID:1612	55-68
ductal carcinoma in situ	HP:0030075,DOID:0060074	78-102
No indication for radiotherapy of regional nodes	Eligibility	2
radiotherapy	OAE:0000235	18-30
Large, pendulous breasts (bra size D and over)	Eligibility	3
size	PATO:0000117	30-34
Exclusion Criteria:	Eligibility	4
Regional radiotherapy is indicated	Eligibility	5
radiotherapy	OAE:0000235	9-21
Unable to lie in prone position	Eligibility	6
position	HP:0012830	23-31
Outcome Measurement:	Results	0
Dose Homogeneity 1: PTV	Results	1
Quantitatively compare the 3 D dose distribution in the PTV (Planning Target Volume) and normal tissues in prone position versus supine position	Results	2
target	BAO:0003064	70-76
volume	PATO:0000918	77-83
position	HP:0012830	113-121
position	HP:0012830	136-144
Time frame: 1 day after treatment planning	Results	3
time	PATO:0000165	0-4
day	UO:0000033	14-17
Results 1:	Results	4
Arm/Group Title: Prone	Results	5
Arm/Group Description: Prone position	Results	6
position	HP:0012830	29-37
Overall Number of Participants Analyzed: 10	Results	7
Mean (Standard Deviation)	Results	8
mean	BAO:0002173	0-4
standard deviation	BAO:0002176	6-24
Unit of Measure: Gy  Dmin (Gy) PTV: 9.8         (6.7)	Results	9
Dmean (Gy) PTV: 48.2         (1.2)	Results	10
Dmax (Gy) PTV: 53.6         (0.6)	Results	11
Results 2:	Results	12
Arm/Group Title: Supine	Results	13
Arm/Group Description: Supine position	Results	14
position	HP:0012830	30-38
Overall Number of Participants Analyzed: 10	Results	15
Mean (Standard Deviation)	Results	16
mean	BAO:0002173	0-4
standard deviation	BAO:0002176	6-24
Unit of Measure: Gy  Dmin (Gy) PTV: 8.2         (5.6)	Results	17
Dmean (Gy) PTV: 49.8         (0.8)	Results	18
Dmax (Gy) PTV: 54.8         (1.4)	Results	19
Adverse Events 1:	Adverse Events	0
Total: 0/10 (0.00%)	Adverse Events	1
Adverse Events 2:	Adverse Events	2
